InvestorsHub Logo
Followers 827
Posts 119518
Boards Moderated 15
Alias Born 09/05/2002

Re: willyw post# 694

Thursday, 11/13/2014 11:29:53 AM

Thursday, November 13, 2014 11:29:53 AM

Post# of 2942
Minor correction: EDP-239 is not host-targeted—it’s an NS5A inhibitor. However, ENTA does have a (host-targeted) cyclophilin inhibitor in preclinical development that would make a logical companion for EDP-239 in a 2-drug cocktail wholly owned by ENTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News